References
- Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JDP, van Putten WLJ. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355: 1119–1125
- Debicki MP, Mrozowski M, Debicki PS, Zielinski J, Piotrkowicz N, Petrovich Z. Localized current field hyperthermia in carcinoma of the cervix: 3-D computer simulation of SAR distribution. Int J Hyperthermia 1999; 15: 427–440
- Lutgens L, Van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev 2010; 3: CD006377
- Datta NR, Bose AK, Kapoor HK. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med Gazette 1987; 121: 68–71
- Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada SA. Randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2002; 17: 97–105
- Sharma S, Singhal S, Sandhu AP, Ghoshal S, Gupta BD, Yadav NS. Local thermo-radiotherapy in carcinoma cervix: Improved local control versus increased incidence of distant metastasis. Asia Oceania J Obstet Gynaecol 1991; 17: 5–12
- Chen HW, Fan JJ, Luo W. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chinese J Clin Oncol 1997; 24: 249–251
- Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 2005; 61: 145–153
- Franckena M, Van der Zee J. Use of combined radiation and hyperthermia for gynecological cancer. Curr Opin Obstet Gynecol 2010; 22: 9–14
- Mayr NA, Wang JZ, Lo SS, Zhang D, Grecula JC, Lu L, et al. Translating response during therapy into ultimate treatment outcome: A personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys 2010; 76: 719–727
- Dimopoulos J, Potter R, Lang S, Fidarova E, Georg P, Dorr W, et al. Dose–effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009; 93: 311–315
- Van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kanoda Fund International Forum 2004 – Clinical group consensus. Int J Hyperthermia 2008; 24: 111–122
- Van der Zee J, de Bruijne M. Letter to the editor. Int J Hyperthermia 2006; 22: 433–447
- Haie-Meder C, Chargari C, Rey A, Dumas I, Morice Ph, Magne N. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010; 96: 161–165
- Potter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radioter Oncol 2007; 83: 148–155